How is this different from the ACC/AHA Pooled Cohort Equations (PCE)?

The Framingham Risk Score predicts 10-year coronary heart disease (CHD) risk specifically, while the ACC/AHA Pooled Cohort Equations predict 10-year atherosclerotic cardiovascular disease (ASCVD) risk, which includes both CHD events and stroke. The PCE also includes race as a variable, reflecting different baseline risk rates observed in African American versus white populations in the original cohort studies. Both tools use similar inputs, but the PCE is now the preferred tool in the 2018 AHA/ACC cholesterol guideline for statin decision-making.

Can I use this calculator if I am already on antihypertensive medication?

Yes, but you must enter your blood pressure as treated and select the treated BP option if prompted. The Framingham equation uses separate regression coefficients for treated versus untreated SBP because pharmacologically controlled blood pressure reflects a different underlying vascular risk profile than naturally low blood pressure. Entering a medication-reduced SBP as untreated will underestimate your true baseline risk.

What blood pressure reading should I use if my readings vary significantly?

Use the average of at least two readings from two separate clinic visits over a period of days to weeks, not the same-day average. If home blood pressure monitoring produces consistently lower readings than clinic measurements by more than 10 mmHg, discuss masked hypertension or white coat hypertension with your provider. The calculator is most accurate when the entered SBP reflects your typical resting blood pressure, not a single outlier value.

Does the calculator account for family history or chronic kidney disease?

Standard Framingham-based scores do not incorporate family history or CKD as direct variables. However, the ACC/AHA guideline identifies premature family history of ASCVD (first-degree male relative under 55, female under 65) and CKD (GFR 15 to 59) as risk-enhancing factors that can be used to reclassify borderline-risk patients toward higher risk categories. If you have either of these factors, discuss with your clinician whether your risk score warrants a higher treatment threshold.

How often should this calculation be repeated?

The ACC/AHA guideline recommends reassessing ASCVD risk every 4 to 6 years in adults aged 40 to 79 without known CVD, or more frequently after any significant change in cardiovascular risk factors including blood pressure, lipid levels, smoking status, or diabetes diagnosis. Initiating statin or antihypertensive therapy also warrants recalculation at 6 to 12 months to assess treatment response.

Healthcare & ClinicalPopular

Blood Pressure Risk Score Calculator

Estimate 10-year atherosclerotic cardiovascular disease (ASCVD) risk using the Pooled Cohort Equations with 2019 ACC/AHA guideline-based clinical recommendations and risk factor identification.

Medical Disclaimer

This calculator uses the Pooled Cohort Equations (PCE) from the 2013 ACC/AHA guidelines, updated with 2019 ACC/AHA clinical guidance. It estimates 10-year atherosclerotic cardiovascular disease (ASCVD) risk. Results are estimates and should not replace clinical evaluation. Consult a qualified healthcare provider for personalized assessment and treatment decisions.

Risk Factor Inputs

Age (40 to 79 years)

Sex

Race/Ethnicity

PCE was validated for these groups. Use with caution for other ethnicities.

Systolic Blood Pressure (mmHg)

Total Cholesterol (mg/dL)

HDL Cholesterol (mg/dL)

On BP Medication?

Diabetes?

Current Smoker?

Embed This Calculator on Your Website

Add this free calculator to your blog, website, or CMS with a simple copy-paste embed code.

Introduction

High blood pressure is called the "silent killer" for good reason. The American Heart Association (AHA) estimates that nearly half of American adults have hypertension, yet roughly one in five of those people do not know it. A single blood pressure reading tells you whether you are hypertensive. A risk score calculation tells you what that means for your 10-year cardiovascular trajectory. These are two different clinical questions. This calculator uses validated Framingham Heart Study risk variables, including systolic blood pressure, age, sex, smoking status, total cholesterol, HDL cholesterol, and diabetes status, to estimate your 10-year risk of a major cardiovascular event such as heart attack or stroke. It mirrors the risk stratification framework used in the 2017 ACC/AHA Hypertension Guideline, which replaced the old "stage 1 = 140/90" threshold with a nuanced risk-based treatment approach. Knowing your score helps clinicians decide whether lifestyle intervention or pharmacotherapy is the appropriate next step.

What This Calculator Does

This calculator takes systolic blood pressure (mmHg), age, sex, total cholesterol, HDL cholesterol, smoking status, and presence of diabetes to compute a Framingham-derived 10-year cardiovascular disease (CVD) risk score expressed as a percentage. It then maps that score to the ACC/AHA risk categories: low risk (below 5%), borderline risk (5 to 7.5%), intermediate risk (7.5 to 20%), and high risk (above 20%). The output guides clinicians and patients in understanding whether blood pressure management alone is sufficient or whether multifactorial risk reduction is required.

The Formula

10-Year CVD Risk (%) = 1 - S0^exp(ΣβX - mean ΣβX) | Where ΣβX = sum of regression coefficients × patient variable values from the Framingham sex-specific equation | S0 = baseline 10-year survival probability (0.9533 for women, 0.8816 for men from Framingham cohort)

The Framingham Risk Score uses logistic regression coefficients derived from the Framingham Heart Study cohort. Each risk variable (log age, log total cholesterol, log HDL, log treated systolic BP, log untreated systolic BP, smoking, diabetes) is multiplied by its sex-specific coefficient. The sum is exponentiated, then applied to the baseline survival probability to produce the 10-year absolute CVD risk percentage. The ACC/AHA Pooled Cohort Equations use a similar approach but incorporate race-specific coefficients and a broader outcome set including stroke.

Step-by-Step Example

Gather your most recent blood pressure measurement

Use a resting seated blood pressure taken after 5 minutes of quiet rest. The calculator uses systolic pressure (the first/higher number). Example: 138 mmHg systolic. Do not use an emergency-setting reading or a single at-home measurement taken immediately after exercise.

Enter lipid panel values

Total cholesterol and HDL cholesterol from a fasting lipid panel are required. Example: Total cholesterol 210 mg/dL, HDL 48 mg/dL. These values are typically reported on annual wellness labs. If you have only a non-fasting result, the total cholesterol figure is still usable but may show slight elevation.

Confirm additional risk variables

Enter age (example: 54 years), sex, smoking status (current smoker: yes/no), and whether you have been diagnosed with diabetes. These four variables, alongside BP and cholesterol, are the full input set for the Framingham equation.

Interpret your 10-year risk output

A 54-year-old male with SBP 138, total cholesterol 210, HDL 48, non-smoker, no diabetes: estimated 10-year CVD risk approximately 11.4%, placing him in the intermediate risk category. The ACC/AHA 2017 guideline recommends discussing statin therapy and antihypertensive treatment for intermediate-risk patients with SBP 130 to 139 mmHg.

Real-World Use Cases

Primary Care Annual Wellness Visit

A 52-year-old female nonsmoker presents with a blood pressure of 134/82, total cholesterol 195, HDL 55, no diabetes. Her ASCVD risk calculates at 6.2%, placing her in the borderline risk category. Her physician uses this score to recommend a Mediterranean diet trial and a 90-day lifestyle modification window before considering antihypertensive medication, consistent with the ACC/AHA guideline recommendations for borderline-risk patients with stage 1 hypertension.

Occupational Health Screening

A workplace wellness nurse conducts annual screenings for a manufacturing facility. An employee with uncontrolled SBP of 158 mmHg, total cholesterol 240, HDL 38, and active smoking calculates a 10-year CVD risk of 28.1%, placing him in the high-risk category. The nurse flags for urgent follow-up with his primary care physician rather than a standard 6-month recheck.

Patient-Facing Shared Decision Making

A cardiologist uses the risk score tool during a shared decision-making discussion with a 60-year-old male borderline-hypertensive patient who is resistant to starting medication. Showing the patient that his current profile places him at 18.7% 10-year risk, and that treating his SBP from 142 to 120 mmHg would reduce that estimate to approximately 12%, makes the benefit of treatment concrete and personal rather than statistical and abstract.

Comparison

10-Year CVD Risk	ACC/AHA Category	BP Threshold for Treatment	Recommended Action
Below 5%	Low Risk	SBP ≥ 130 mmHg	Lifestyle modification; annual recheck
5% to 7.5%	Borderline Risk	SBP ≥ 130 mmHg	Risk-enhancing factor review; lifestyle changes
7.5% to 20%	Intermediate Risk	SBP ≥ 130 mmHg	Discuss antihypertensive therapy + statin
Above 20%	High Risk	SBP ≥ 130 mmHg	Antihypertensive + statin therapy recommended
Any %	Stage 2 Hypertension (SBP ≥ 140)	Immediate	Medication initiation regardless of risk score

Common Mistakes to Avoid

Using a single blood pressure measurement taken in a non-resting state. White coat hypertension can inflate SBP by 10 to 20 mmHg in a clinical setting. The ACC/AHA recommends averaging at least two readings taken on two separate occasions. Using an acute stress-response reading will overestimate CVD risk and may lead to inappropriate treatment escalation.
Omitting treatment status when entering blood pressure. The Framingham equation uses separate coefficients for treated versus untreated systolic blood pressure. Entering a treated SBP of 125 mmHg as if it were untreated underestimates baseline risk, because the treated SBP reflects pharmacological intervention, not the patient's underlying vascular status.
Applying the score to patients outside the validated age range. The Framingham Risk Score is validated for adults aged 30 to 74. Using it in a 26-year-old or a 78-year-old produces outputs that are outside the model's calibrated performance range. For patients outside this range, refer to age-appropriate risk tools or use clinical judgment with a cardiologist.

Frequently Asked Questions

Accuracy and Disclaimer

This calculator provides an estimated 10-year cardiovascular disease risk based on Framingham Heart Study equations and is intended for educational and informational purposes only. Results are not a substitute for clinical evaluation by a licensed healthcare professional. Blood pressure risk assessment requires accurate measurement, consideration of patient-specific medical history, and clinical judgment. Do not make medication or treatment decisions based solely on this calculator. Consult your physician or cardiologist for personalized cardiovascular risk assessment and management.

Conclusion

Blood pressure risk scoring is not a one-time calculation. Weight changes, statin initiation, smoking cessation, and antihypertensive therapy all shift your risk profile over time. Recalculate every 12 months or after any significant lifestyle or medication change. For a full cardiovascular picture, pair this tool with the BMI Body Fat Calculator to assess weight-related cardiovascular load, and use the Medication Dosage Calculator if your clinician has initiated antihypertensive pharmacotherapy and you need to verify dosing parameters.

Related Healthcare & Clinical Calculators

Healthcare & Clinical

BMI Calculator

Calculate your Body Mass Index (BMI) using height and weight. Get your BMI category (underweight, normal, overweight, obese) with professional health context and interpretation.

Use Calculator Healthcare & Clinical